Английская Википедия:C2-Symmetric ligands

Содержание

Текст

Текст

Текст

Текст

Текст

Текст

Текст

Текст

Текст

In homogeneous catalysis, C₂-symmetric ligands refer to ligands that lack mirror symmetry but have C₂ symmetry (two-fold rotational symmetry). Such ligands are usually bidentate and are valuable in catalysis. The C₂ symmetry of ligands limits the number of possible reaction pathways and thereby increases enantioselectivity, relative to asymmetrical analogues. C₂-symmetric ligands are a subset of chiral ligands. Chiral ligands, including C₂-symmetric ligands, combine with metals or other groups to form chiral catalysts. These catalysts engage in enantioselective chemical synthesis, in which chirality in the catalyst yields chirality in the reaction product.

Examples

An early C₂-symmetric ligand, diphosphine catalytic ligand DIPAMP, was developed in 1968 by William S. Knowles and coworkers of Monsanto Company, who shared the 2001 Nobel Prize in Chemistry. This ligand was used in the industrial production of [[L-DOPA|Шаблон:Sc-DOPA]].

Файл:L-dopaSyn.svg

Synthesis of Шаблон:Sc-DOPA via hydrogenation with C₂-symmetric diphosphine.

Some classes of C₂-symmetric ligands are called privileged ligands, which are ligands that are broadly applicable to multiple catalytic processes, not only a single reaction type.

• Ligands and Complexes
• The C2-symmetric diphosphine DIOP is historically significant.[5]

  The C₂-symmetric diphosphine DIOP is historically significant.

• DuPhos ligands are a class of C2-symmetric ligands for asymmetric hydrogenation.[6]

  DuPhos ligands are a class of C₂-symmetric ligands for asymmetric hydrogenation.

• Oxaliplatin, containing the C2-symmetric (R,R)-diaminocyclohexane ligand, is an important anticancer drug.

  Oxaliplatin, containing the C₂-symmetric (R,R)-diaminocyclohexane ligand, is an important anticancer drug.

• Jacobsen's epoxidation catalyst is a complex of a C2-symmetric salen-type ligand.

  Jacobsen's epoxidation catalyst is a complex of a C₂-symmetric salen-type ligand.

• C2-symmetric diene ligand.[7]

  C₂-symmetric diene ligand.

• Both bi- and tridentate bis(oxazoline) ligands are used in organic synthesis

  Both bi- and tridentate bis(oxazoline) ligands are used in organic synthesis

• Both enantiomers of BINAP

  Both enantiomers of BINAP

• BINOL, another binaphthalene-based ligand

  BINOL, another binaphthalene-based ligand

• TADDOL

  TADDOL

• DIPAMP, a diphosphine of historic significance

  DIPAMP, a diphosphine of historic significance

• AD-mix α, dihydroquinine derivative used in Sharpless asymmetric dihydroxylation

  AD-mix α, dihydroquinine derivative used in Sharpless asymmetric dihydroxylation

Mechanistic concepts

While the presence of any symmetry element within a ligand intended for asymmetric induction might appear counterintuitive, asymmetric induction only requires that the ligand be chiral (i.e. have no improper rotation axis). Asymmetry (i.e. absence of any symmetry elements) is not required. C₂ symmetry improves the enantioselectivity of the complex by reducing the number of unique geometries in the transition states. Steric and kinetic factors then usually favor the formation of a single product.

Файл:C2-symmetry in BOX ligands.png

The left hand structure has a C₂‑rotational axis whereas the right hand structure is asymmetric. Arrows indicate the proposed trajectories for attack by substrates, identical colours lead to identical transition states (and hence products) with red arrows being disfavoured due to steric repulsion.

Chiral fence

The chiral fence

The chiral fence

Chiral ligands work by asymmetric induction somewhere along the reaction coordinate. The image to the right illustrates how a chiral ligand may induce an enantioselective reaction. The ligand (in green) has C₂ symmetry with its nitrogen, oxygen or phosphorus atoms hugging a central metal atom (in red). In this particular ligand the right side is sticking out and its left side points away. The substrate in this reduction is acetophenone and the reagent (in blue) a hydride ion. In absence of the metal and the ligand the Re face approach of the hydride ion gives the (S)-enantiomer and the Si face approach the (R)-enantiomer in equal amounts (a racemic mixture like expected). The ligand and metal presence changes all that. The carbonyl group will coordinate with the metal and due to the steric bulk of the phenyl group it will only be able to do so with its Si face exposed to the hydride ion with in the ideal situation exclusive formation of the (R) enantiomer. The re face will simply hit the chiral fence. Note that when the ligand is replaced by its mirror image the other enantiomer will form and that a racemic mixture of ligand will once again yield a racemic product. Also note that if the steric bulk of both carbonyl substituents is very similar the strategy will fail.

Other C₂-symmetric complexes

Many C₂-symmetric complexes are known. Some arise not from C₂-symmetric ligands, but from the orientation or disposition of high symmetry ligands within the coordination sphere of the metal. Notably, EDTA and triethylenetetraamine form complexes that are C₂-symmetric by virtue of the way the ligands wrap around the metal centers. Two isomers are possible for (indenyl)₂MX₂, C_s- and C₂-symmetric. The C₂-symmetric complexes are optically stable.

Asymmetric ligands

Ligands containing atomic chirality centers such asymmetric carbon, which usually do not have C₂-symmetry, remain important in catalysis. Examples include cinchona alkaloids and certain phosphoramidites. P-chiral monophosphines have also been investigated.

See also

• Chiral anion catalysis

Further reading

• Шаблон:Cite journal
• Шаблон:Cite journal
• Шаблон:Cite journal
• Шаблон:Cite journal
• Шаблон:Cite journal